Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Organon & Co. Common Stock (OGN) vs Rigetti Computing Inc (RGTI) Price & Performance

Organon & Co. Common StockTrade
Rigetti Computing IncTrade

Price performance (Past 24H)

Key statistics

Organon & Co. Common Stock vs Rigetti Computing Inc — how do they compare? Organon & Co. Common Stock trades at $13.58 (market cap $3.62B), while Rigetti Computing Inc trades at $11.58 (market cap $4.27B). The key difference: Rigetti Computing Inc is the larger of the two by market cap, and Organon & Co. Common Stock pays a 0.58% dividend while Rigetti Computing Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Organon & Co. Common Stock for 0 Days and Rigetti Computing Inc for 36 Days on average.

OGNRGTI
Market Cap
$3.62B$4.27B
Volume
2,892,99914,966,259
Sector
HealthTechnology
52-Week High
$13.81$56.34
52-Week Low
$5.70$11.68
Typical Hold Time
0 Days36 Days
Enterprise Value
$11.04B$3.88B
Dividend Yield
0.58%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Organon & Co. Common Stock

Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.

OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.

Rigetti Computing Inc

RGTI trades at $12.78, down 3.55% today, with bearish technical signals but strong analyst support. The company shows negative profitability with a -1,787.4% net income margin despite recent earnings beats. Revenue growth from $7M to $13M (2025-2026) is overshadowed by escalating losses. Cash flow remains negative, though financing activities provide liquidity. Recent quantum computing sector news highlights competitive positioning and technological advancements.

Outlook remains speculative with high execution risk; Wall Street consensus is bullish (85.7% buy ratings) with a $21.67 price target implying 70% upside. Key risks include sustained losses, intense competition, and reliance on future quantum technology adoption. The stock offers high-risk growth potential for investors comfortable with speculative emerging technology plays.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

OGN
100% Buy0% Sell
Avg holding period · 0 Days
RGTI
64% Buy36% Sell
Avg holding period · 36 Days

Top news

Latest headlines on both assets

About Organon & Co. Common Stock

Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.

Read more on OGN →

About Rigetti Computing Inc

Rigetti Computing, Inc. is a pioneer in quantum computing, focusing on developing and deploying quantum-classical computing systems. The company designs and fabricates superconducting quantum processors and integrates them with a full-stack software and control platform. Rigetti offers access to its quantum computers through the cloud, aiming to solve complex computational problems that are intractable for classical computers, with applications in finance, chemistry, and machine learning.

Read more on RGTI →